| Complement opsonization of nanoparticles: Differences between humans and preclinical species Y Li, G Wang, L Griffin, NK Banda, LM Saba, EV Groman, R Scheinman, ... Journal of Controlled Release 338, 548-556, 2021 | 30 | 2021 |
| Liposomal extravasation and accumulation in tumors as studied by fluorescence microscopy and imaging depend on the fluorescent label G Wang, M Zannikou, L Lofchy, Y Li, H Gaikwad, IV Balyasnikova, ... ACS nano 15 (7), 11880-11890, 2021 | 22 | 2021 |
| Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro G Wang, H Gaikwad, MK McCarthy, M Gonzalez-Juarrero, Y Li, ... Precision nanomedicine 4 (1), 724, 2021 | 17 | 2021 |
| Complement inhibitors block complement C3 opsonization and improve targeting selectivity of nanoparticles in blood H Gaikwad, Y Li, G Gifford, E Groman, NK Banda, L Saba, R Scheinman, ... Bioconjugate chemistry 31 (7), 1844-1856, 2020 | 17 | 2020 |
| Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins Y Li, S Jacques, H Gaikwad, G Wang, NK Banda, VM Holers, ... Nature Nanotechnology 19 (2), 246-254, 2024 | 15 | 2024 |
| PEGylated Liposomes Accumulate in the Areas Relevant to Skin Toxicities via Passive Extravasation across “Leaky” Endothelium Y Li, L Lofchy, G Wang, H Gaikwad, M Fujita, D Simberg ACS nano 16 (4), 6349-6358, 2022 | 14 | 2022 |
| Antibody-dependent complement responses toward SARS-CoV-2 receptor-binding domain immobilized on “pseudovirus-like” nanoparticles H Gaikwad, Y Li, G Wang, R Li, S Dai, C Rester, R Kedl, L Saba, ... ACS nano 16 (6), 8704-8715, 2022 | 10 | 2022 |
| Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors IV Balyasnikova, M Zannikou, G Wang, Y Li, JT Duffy, RN Levine, ... Journal of Controlled Release 349, 413-424, 2022 | 8 | 2022 |
| Surface Modification of Erythrocytes with Lipid Anchors: Structure–Activity Relationship for Optimal Membrane Incorporation, in vivo Retention, and Immunocompatibility H Gaikwad, G Wang, Y Li, D Bourne, D Simberg Advanced nanobiomed research 2 (8), 2200037, 2022 | 4 | 2022 |
| Optimized Enzyme-Linked Immunosorbent Assay for Anti-PEG Antibody Detection in Healthy Donors and Patients Treated with PEGylated Liposomal Doxorubicin Y Li, U Ettah, S Jacques, H Gaikwad, A Monte, L Dylla, S Guntupalli, ... Molecular Pharmaceutics, 2024 | 2 | 2024 |
| Validation of dot blot immunoassay for measurement of complement opsonization of nanoparticles Y Li, A Monte, L Dylla, SM Moghimi, D Simberg Journal of Immunological Methods 528, 113668, 2024 | 2 | 2024 |
| Fast and scalable lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro G Wang, H Gaikwad, MK McCarthy, M Gonzalez-Juarrero, Y Li, ... bioRxiv, 2020.12. 18.423509, 2020 | 1 | 2020 |
| Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts Y Li, L Saba, RI Scheinman, NK Banda, M Holers, A Monte, L Dylla, ... ACS nano, 2024 | | 2024 |
| Complement-dependent uptake of nanoparticles by blood phagocytes: brief overview and perspective Y Li, SM Moghimi, D Simberg Current Opinion in Biotechnology 85, 103044, 2024 | | 2024 |
